Top segments and regional performance

Last year, the company generated ‪68.13 B‬ INR, the most of which — ‪68.13 B‬ INR — came from its top-performing segment, Active Pharmaceutical Ingredients, compared to ‪55.54 B‬ INR the previous year. The greatest contribution came from International, which accounted for ‪45.69 B‬ INR last year, with ‪38.00 B‬ INR the year before.